October 03, 2004

Vioxx Recalled, Vioxx Withdrawal Causes Concern About FDA

"Merck & Co. is pulling its blockbuster arthritis drug Vioxx off the market because a clinical trial found an increased risk of heart attack and stroke."

"The problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug."

Posted by news editor | Filed under: Heart Attacks